Department of Nephrology, Yokohama Rosai Hospital, Kanagawa, Japan; Department of Medicine, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan; Kidney and Vascular Pathology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
Department of Nephrology, Yokohama Rosai Hospital, Kanagawa, Japan.
Am J Kidney Dis. 2015 Dec;66(6):1095-100. doi: 10.1053/j.ajkd.2015.08.016. Epub 2015 Sep 9.
AH amyloidosis is a rare type of amyloidosis caused by deposition of monoclonal immunoglobulin heavy chain. The key diagnostic feature is positive immunostaining for a single class of immunoglobulin heavy chain. We report a case of AH amyloidosis with immunoglobulin G (IgG) λ monoclonal gammopathy that was diagnosed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) after immunostaining of renal tissue for immunoglobulin heavy chain gave negative results. The molecular weight of the purified renal amyloid protein was ∼11kDa, which was determined by LC-MS/MS analysis to correspond to an amino acid sequence comprising the variable region and a truncated portion of the constant region of IgG heavy chain. The exact same truncated heavy chain was detected by LC-MS/MS of a protein isolated from the patient's serum, suggesting that the truncated serum protein was the precursor of the amyloid protein. Because antibodies to immunoglobulin heavy chain recognize the Fc portion, the large deletion in the constant region could explain the negative results upon immunostaining. Direct protein detection by LC-MS/MS is a powerful aid to diagnose renal AH amyloidosis, particularly when the findings of immunoglobulin staining are inconsistent with the background monoclonal gammopathy.
淀粉样变是一种由单克隆免疫球蛋白重链沉积引起的罕见类型的淀粉样变性。其关键诊断特征是对单一类别免疫球蛋白重链呈阳性免疫染色。我们报告了一例免疫球蛋白 G(IgG)λ单克隆丙种球蛋白病的淀粉样变,肾组织免疫球蛋白重链染色结果为阴性,通过液相色谱-串联质谱(LC-MS/MS)检测后确诊。纯化的肾淀粉样蛋白的分子量约为 11kDa,通过 LC-MS/MS 分析确定其对应于 IgG 重链可变区和恒定区截断部分的氨基酸序列。通过从患者血清中分离的蛋白质的 LC-MS/MS 检测到完全相同的截断重链,表明截断的血清蛋白是淀粉样蛋白的前体。因为免疫球蛋白重链的抗体识别 Fc 部分,所以恒定区的大缺失可以解释免疫染色的阴性结果。通过 LC-MS/MS 直接检测蛋白质是诊断肾 AH 淀粉样变性的有力辅助手段,尤其是当免疫球蛋白染色的结果与背景单克隆丙种球蛋白病不一致时。